View in EDS HTML Full Text PDF Full Text

Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials.

Saved in:
Bibliographic Details
Title: Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials.
Authors: Nguyen, Jessie1 (AUTHOR) joanne.tang@sa.gov.au, Nindra, Udit1,2 (AUTHOR) walid.zwieky@health.nsw.gov.au, Tang, Joanne1,3 (AUTHOR), Zwieky, Walid1,4 (AUTHOR), Hong, Jun Hee1 (AUTHOR), Hong, Martin1,2 (AUTHOR), Descallar, Joseph2,3 (AUTHOR), Killen, Andrew3,4 (AUTHOR), Cooper, Adam1,4 (AUTHOR), Wilkinson, Kate1 (AUTHOR), Pal, Abhijit1 (AUTHOR), Teng, Christina3 (AUTHOR), Roohullah, Aflah1,4 (AUTHOR), Wei, Joe3 (AUTHOR), Ng, Weng1 (AUTHOR), Lemech, Charlotte3 (AUTHOR), Chua, Wei1,4 (AUTHOR)
Source: Cancers. Apr2026, Vol. 18 Issue 8, p1242. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers18081242